Technetium Tc-99M
Technetium Tc-99m is a radioactive diagnostic agent used across several products for imaging the brain, thyroid, salivary glands, urinary bladder, nasolacrimal drainage system, and to help locate abdominal infections.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 2 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Technetium Tc-99M: Patient Information Guide
A plain-language walkthrough of Technetium Tc-99M — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Technetium Tc-99m is a radioactive imaging agent used across multiple products to help visualize organs and detect areas of disease. The specific approved uses depend on the product.
- Ceretec (adults and children ages 2–17): Used to help locate infections and inflammatory bowel disease inside the abdomen by labeling white blood cells (leukocyte labeled scintigraphy)
- Ceretec (adults and children ages 2–17): Used to detect areas of reduced blood flow in the brain following a stroke (cerebral scintigraphy)
- Ultra-Technekow (adults): Used for thyroid gland imaging
- Ultra-Technekow (adults): Used for salivary gland imaging
- Ultra-Technekow (adults): Used for urinary bladder imaging to detect vesico-ureteral reflux (backflow of urine from the bladder into the ureters)
- Ultra-Technekow (adults): Used for nasolacrimal drainage system imaging (dacryoscintigraphy) to check tear duct function
- Ultra-Technekow (pediatric patients): Used for thyroid imaging and urinary bladder imaging to detect vesico-ureteral reflux
⚙️How it works▾
Technetium Tc-99m works as a radioactive tracer — it emits a signal that a special camera can detect, allowing doctors to create images of how organs and tissues look and function. With Ceretec, the Tc-99m forms a fat-soluble compound that can cross the blood-brain barrier (the protective filter between the bloodstream and the brain) and enter white blood cells. In brain imaging, it gets taken up by brain tissue in proportion to blood flow and becomes trapped there, highlighting areas with reduced circulation. For infection imaging, it enters white blood cells, which then travel to sites of infection or inflammation — making those areas visible on the scan. With Ultra-Technekow, a different form of Tc-99m (sodium pertechnetate) concentrates naturally in organs such as the thyroid, salivary glands, and bladder lining, where its radioactive signal is detected by the imaging camera.
💊How it's taken▾
Technetium Tc-99m is always administered by trained healthcare professionals in a clinical setting — it is never self-administered at home. The route of administration depends on the product and the scan being performed.
- Ceretec is given as an intravenous (IV) injection into a vein; for leukocyte (white blood cell) labeling, it must be given as soon as possible after preparation — preferably within 20 minutes and no later than 1 hour
- Ceretec for brain imaging is given by IV injection, with imaging starting 30–90 minutes later and completed within 4 hours
- Ultra-Technekow sodium pertechnetate is given by IV injection for thyroid, salivary gland, and tear duct imaging; for bladder imaging, it is instilled directly into the bladder through a catheter; for tear duct imaging, it is placed using a small device near the eye
- After any Tc-99m procedure, drink plenty of fluids and urinate frequently to help clear the radioactive material and reduce radiation to the kidneys and bladder
🤒Side effects — in detail▾
Most people tolerate Technetium Tc-99m scans well, but some side effects have been reported with Ceretec:
- Temporary increase in blood pressure (the most commonly reported effect)
- Flushing (sudden warmth or redness)
- Nausea or vomiting
- Headache
- Dizziness
- Tingling or unusual skin sensations (paresthesia)
- Fatigue or general feeling of being unwell
- Fever
Serious allergic reactions — including anaphylaxis (a severe, whole-body allergic response with facial swelling, rash, or difficulty breathing) — have been reported. Emergency equipment and trained staff are present during your scan specifically to manage this if it occurs. Tell your care team immediately if you feel unwell during or after the procedure.
⚠️Warnings & precautions▾
- Radiation exposure: Every use of Tc-99m adds to your lifetime radiation total, which is associated with a small increased risk of cancer over time. Drinking fluids and urinating frequently after the scan helps limit this exposure. Children face greater radiation risks than adults because they are more sensitive to radiation and have more years ahead — the younger the child, the greater the concern.
- Allergic reactions: Serious hypersensitivity reactions, including life-threatening anaphylaxis, have been reported with Ceretec. Medical staff have resuscitation equipment available and will monitor you throughout the procedure.
- Image interpretation errors: For leukocyte-labeled scans, other conditions — such as tumors, recent tissue damage, or unrelated inflammation — can affect how the images look and may make results harder to interpret accurately.
- Kidney impairment: This agent is largely cleared through the kidneys. Patients with reduced kidney function may receive higher radiation exposure, so their care team may adjust the dose accordingly.
🔀What it interacts with▾
The FDA labels for Technetium Tc-99m products do not list specific drug, food, or supplement interactions.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Pregnancy: Tc-99m crosses the placenta and can expose a developing baby to radiation. The risks depend on the stage of pregnancy and the amount of radioactivity used. Discuss the risks and benefits carefully with your doctor if you are or may be pregnant.
- Breastfeeding: If you are breastfeeding and receive Ceretec, you should pump and discard breast milk for 12 to 24 hours after the injection to protect your infant from radiation exposure.
- Children: Ceretec is approved for children ages 2–17 for its specific uses. It has not been established as safe or effective in children under age 2. Children carry a higher radiation risk than adults.
- Older adults: Elderly patients may need to start at the lower end of the dose range because aging can affect kidney, liver, and heart function.
- Kidney problems: Because Tc-99m is substantially cleared through the kidneys, patients with impaired kidney function may receive more radiation exposure. Your care team may consider adjusting the dose.
📡Pharmacodynamics — effects in the body▾
The exact relationship between Tc-99m exametazime blood levels and successful imaging is not fully established. The agent works by distributing to specific tissues — brain gray matter, white blood cells, or organs like the thyroid — where its radioactive signal is captured by an external camera to create diagnostic images. It does not treat or alter disease; it reveals how tissues are functioning at the time of the scan.
🔬Pharmacokinetics — how your body processes it▾
After IV injection of Ceretec (Tc-99m exametazime), the compound is rapidly cleared from the blood. Brain uptake peaks within one minute, reaching 3.5–7% of the injected dose, and most of what stays in the brain remains there for up to 24 hours (decaying naturally). When used to label white blood cells, the tracer is seen in the lungs, liver, spleen, bone marrow, kidneys, and bladder in the first hour, then shifts more toward the bone marrow and bowel over time. The body clears the agent through two main routes: about 40% is excreted in urine over 48 hours, and about 50% of the portion that reaches the gut is passed through the intestinal tract over the same period.
📦How to store it▾
Store Ceretec kits at controlled room temperature 15°C to 25°C (59°F to 77°F). Store and dispose of technetium Tc 99m exametazime in compliance with the regulations of the government agency authorized to license the use of this radionuclide.
📄 Written from Technetium Tc-99M’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Technetium Tc-99M — the kind of thing our pharmacy team would talk through with you at the counter.
Is Technetium Tc-99m a medicine that treats my condition? ▾
Should I be worried about the radiation from this scan? ▾
What should I do after the scan to protect myself? ▾
Can I breastfeed after receiving this injection? ▾
Are there any side effects I should watch for? ▾
I'm pregnant — is it safe to have this scan? ▾
Is Technetium Tc-99M available over the counter? ▾
When was Technetium Tc-99M first available? ▾
Who makes Technetium Tc-99M? ▾
💬 Answers drafted from Technetium Tc-99M’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Technetium Tc-99M comes
Technetium Tc-99M is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Injection
How this form is used
- Ceretec is used to help locate intraabdominal infections and inflammatory bowel disease by labeling white blood cells with the radioactive tracer
- Ceretec is used to detect areas of reduced blood flow in the brain after a stroke (cerebral scintigraphy)
- Ultra-Technekow provides Tc-99m used for thyroid imaging, salivary gland imaging, nasolacrimal drainage system imaging, and urinary bladder imaging in adults
- Ultra-Technekow provides Tc-99m used for thyroid imaging and urinary bladder imaging in pediatric patients
- Ceretec is given as an intravenous injection; for leukocyte labeling, it must be administered as soon as possible after preparation — preferably within 20 minutes and no later than 1 hour
- Ceretec for cerebral scintigraphy is given by intravenous injection; imaging is performed 30–90 minutes after administration and completed within 4 hours
- Ultra-Technekow sodium pertechnetate Tc-99m is given by intravenous injection for most uses, but is instilled directly into the bladder via catheter for urinary bladder imaging and placed in the eye area for nasolacrimal drainage imaging
- After receiving any Tc-99m product, drink plenty of fluids and urinate frequently to help reduce radiation exposure to the kidneys and bladder
Show 22 more strengths Show fewer strengths
📊 Technetium Tc-99M across the U.S. market
How Technetium Tc-99M appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Technetium Tc-99M is used
A general measure of how commonly Technetium Tc-99M is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q3–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Technetium Tc-99M is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Technetium Tc-99M prescribed? Of the 1,596 medications we measure, Technetium Tc-99M ranks #1,199 by Medicaid prescriptions — more than 25% of them.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Technetium Tc-99M, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 4 of 33 listed Technetium Tc-99M NDCs with Medicaid activity.
🔍 Compare Technetium Tc-99M products
A representative set of FDA-listed product records for Technetium Tc-99M — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 1 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| 1.5 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| 2 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| 2.5 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| 3 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| 3.5 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| 5 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| 6 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| 7.5 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| 11 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| 14 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| 16 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| 19 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| TECHNETIUM TC-99M SODIUM PERTECHNETATE 1 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| TECHNETIUM TC-99M SODIUM PERTECHNETATE 1.5 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| TECHNETIUM TC-99M SODIUM PERTECHNETATE 2 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| TECHNETIUM TC-99M SODIUM PERTECHNETATE 2.5 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| TECHNETIUM TC-99M SODIUM PERTECHNETATE 3 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| TECHNETIUM TC-99M SODIUM PERTECHNETATE 3.5 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| TECHNETIUM TC-99M SODIUM PERTECHNETATE 5 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| TECHNETIUM TC-99M SODIUM PERTECHNETATE 6 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| TECHNETIUM TC-99M SODIUM PERTECHNETATE 7.5 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| TECHNETIUM TC-99M SODIUM PERTECHNETATE 11 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| TECHNETIUM TC-99M SODIUM PERTECHNETATE 14 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| TECHNETIUM TC-99M SODIUM PERTECHNETATE 16 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| TECHNETIUM TC-99M SODIUM PERTECHNETATE 19 Ci | Intravenous | Curium US LLC | NDA | View NDC → |
| 0.5 mg/5 mL | Intravenous | Medi-Physics Inc. dba GE Healthcare. × 2 listings | NDA | View NDC → |
| 1 mg/10 mL | Intravenous | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
Showing 29 of 29 products — FDA National Drug Code Directory. See every product, package size and price: browse all 29 Technetium Tc-99M NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Technetium Tc-99M — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Technetium Tc-99M in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Technetium Tc-99M went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
📦 Supply & shortage status
Whether Technetium Tc-99M is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 2 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Curium US LLC is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.